Immunovia AB (publ) (IMMVF)
IMMVF Stock Price Chart
Explore Immunovia AB (publ) interactive price chart. Choose custom timeframes to analyze IMMVF price movements and trends.
IMMVF Company Profile
Discover essential business fundamentals and corporate details for Immunovia AB (publ) (IMMVF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
28 Jun 2019
Employees
9.00
Website
https://www.immunovia.comCEO
Jeff Borcherding
Description
Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
IMMVF Financial Timeline
Browse a chronological timeline of Immunovia AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 19 Nov 2025
Earnings released on 28 Aug 2025
Earnings released on 14 May 2025
EPS came in at -$0.02 , while revenue for the quarter reached $13.88K , missing expectations by -98.61%.
Earnings released on 25 Feb 2025
EPS came in at $0.00 , while revenue for the quarter reached $40.95K .
Earnings released on 27 Nov 2024
EPS came in at -$0.11 , while revenue for the quarter reached $22.65K .
Earnings released on 5 Aug 2024
EPS came in at -$0.05 , while revenue for the quarter reached $8.04K .
Earnings released on 29 Apr 2024
EPS came in at -$0.01 , while revenue for the quarter reached $14.38K .
Earnings released on 21 Feb 2024
EPS came in at -$0.11 , while revenue for the quarter reached $15.43K .
Stock split effective on 4 Dec 2023
Shares were split 1077 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Sept 2023
EPS came in at -$0.08 , while revenue for the quarter reached $44.30K .
Earnings released on 30 Jun 2023
EPS came in at -$0.37 , while revenue for the quarter reached $37.97K .
Earnings released on 31 Mar 2023
EPS came in at -$0.22 , while revenue for the quarter reached $49.96K .
Earnings released on 23 Feb 2023
EPS came in at -$0.27 , while revenue for the quarter reached $49.02K , missing expectations by -74.34%.
Earnings released on 10 Nov 2022
EPS came in at -$0.09 , while revenue for the quarter reached $31.95K , missing expectations by -55.48%.
Earnings released on 24 Aug 2022
EPS came in at -$0.14 , while revenue for the quarter reached $10.01K , missing expectations by -79.44%.
Earnings released on 28 Apr 2022
EPS came in at -$0.21 , while revenue for the quarter reached $19.40K .
Earnings released on 17 Feb 2022
EPS came in at -$0.21 , while revenue for the quarter reached $33.62K , missing expectations by -94.45%.
Earnings released on 11 Nov 2021
EPS came in at -$0.17 , while revenue for the quarter reached $42.94K .
Earnings released on 19 Aug 2021
EPS came in at -$0.24 , while revenue for the quarter reached $4.43K .
Earnings released on 28 Apr 2021
EPS came in at -$0.11 , while revenue for the quarter reached $14.07K .
Earnings released on 17 Feb 2021
EPS came in at -$0.25 , while revenue for the quarter reached $18.45K .
Earnings released on 12 Nov 2020
EPS came in at -$0.17 , while revenue for the quarter reached $4.13K .
IMMVF Stock Performance
Access detailed IMMVF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.